Skip to main content
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.392
-0.003 (-0.63%)
At close: Mar 9, 2026, 4:00 PM EDT
0.385
-0.006 (-1.61%)
After-hours: Mar 9, 2026, 7:41 PM EDT

Mereo BioPharma Group Revenue

Mereo BioPharma Group had revenue of $500.00K in the twelve months ending September 30, 2025, down -50.00% year-over-year.

Revenue (ttm)
$500.00K
Revenue Growth
-50.00%
P/S Ratio
124.63
Revenue / Employee
$13,889
Employees
36
Market Cap
62.32M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202149.37M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ImmuCell 27.64M
TScan Therapeutics 10.33M
NeurAxis 3.36M
BeyondSpring 1.88M
ImageneBio 800.00K
Spruce Biosciences 697.00K
InflaRx 73.73K
eXoZymes -700.00
Revenue Rankings

MREO News

More News